Qiagen clinical insight surpasses one million patient test cases analyzed and interpreted

Qiagen Clinical Insight (QCI) has achieved a milestone of more than one million patient test cases analyzed and interpreted. The cloud-based QCI software has delivered insights to clinical laboratories and physicians in North America, Europe, and the Asia-Pacific regions, enabling and advancing the practice of precision medicine. QCI provides all of the capabilities required to transform complex data from next-generation sequencing into actionable insights without the need for a customer to build a complex bioinformatics framework or high operational overhead. The two main components of the platform are QCI analyze, automating the analysis of raw sequencing data to identify variants, and QCI interpret, guiding the consistent and reproducible evidence-based interpretation and reporting of variants through the automation of guidelines set by industry experts, such as ACMG, AMP, ASCO, and CAP.